Back to search
Snakebite
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Snakebite trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Snakebite trials you may qualify forSnake bite affects thousands of Australians every year, but few die as a result due to high quality first aid and timely medical care. Good first aid should be…
Early identification of tissue injury from a rattlesnake bite is critical to prevent complications and reduce health care costs. Given the limitations of clinic…
Snakebite envenomation (SBE) is a major public health problem in many developing countries. Standard snake antivenom (SA) remains the primary treatment and has…
In 2017, the World Health Organization placed snakebites at the top of its list of neglected tropical diseases in an effort to facilitate funding for prevention…
Bites by venomous snakes can cause disability and can be life-threatening. We are doing research in adult patients to try and find medications that can be admin…
Snakebite causes approximately 138,000 deaths each year and non-fatal bites lead to considerable health burden, particularly in low-income tropical countries. D…
There is little or no assessment under real-use conditions of the efficacy and the tolerance in the short, medium and long term of the antivenoms currently on t…